ANP32A regulates histone H3 acetylation and promotes leukemogenesis

Xuejing Yang, Bin Lu, Xueqin Sun, Cuijuan Han, Chunling Fu, Kailin Xu, Min Wang, Dengju Li, Zhichao Chen, Puneet Opal, Qiang Wen, John D. Crispino, Qian Fei Wang, Zan Huang*

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Deregulation of key regulators of histone modification is important in the initiation and progression of human leukemia. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) participates in histone acetylation and its role in acute myeloid leukemia remains unclear. Here we observed significant upregulation of ANP32A in primary AML cells, which was essential for AML cell proliferation, survival, and colony formation. Integrative analysis of the genome-wide histone H3 acetylation and gene expression demonstrated that ANP32A deficiency reduced histone H3 acetylation, in accordance with changes in gene expression. Notably, significant histone H3 acetylation enrichment was associated with mRNA changes in lipid-related genes, including APOC1, PCSK9, P2RX1, and LPPR3. Indeed, over-expression of APOC1 partially compensated the proliferation-defect phenotype in ANP32A deficient AML cells while APOC1 knockdown alone mimicked the effect of ANP32A deficiency. Collectively, our data indicate that ANP32A is a novel regulator of histone H3 acetylation and promotes leukemogenesis.

Original languageEnglish (US)
Pages (from-to)1587-1597
Number of pages11
JournalLeukemia
Volume32
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Phosphoproteins
Acetylation
Leucine
Histones
Histone Code
Gene Expression
Acute Myeloid Leukemia
Cell Survival
Leukemia
Up-Regulation
Cell Proliferation
Genome
Phenotype
Lipids
Messenger RNA
Genes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Yang, X., Lu, B., Sun, X., Han, C., Fu, C., Xu, K., ... Huang, Z. (2018). ANP32A regulates histone H3 acetylation and promotes leukemogenesis. Leukemia, 32(7), 1587-1597. https://doi.org/10.1038/s41375-018-0010-7
Yang, Xuejing ; Lu, Bin ; Sun, Xueqin ; Han, Cuijuan ; Fu, Chunling ; Xu, Kailin ; Wang, Min ; Li, Dengju ; Chen, Zhichao ; Opal, Puneet ; Wen, Qiang ; Crispino, John D. ; Wang, Qian Fei ; Huang, Zan. / ANP32A regulates histone H3 acetylation and promotes leukemogenesis. In: Leukemia. 2018 ; Vol. 32, No. 7. pp. 1587-1597.
@article{56e6e1077bee4230ae78ed45203c1f56,
title = "ANP32A regulates histone H3 acetylation and promotes leukemogenesis",
abstract = "Deregulation of key regulators of histone modification is important in the initiation and progression of human leukemia. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) participates in histone acetylation and its role in acute myeloid leukemia remains unclear. Here we observed significant upregulation of ANP32A in primary AML cells, which was essential for AML cell proliferation, survival, and colony formation. Integrative analysis of the genome-wide histone H3 acetylation and gene expression demonstrated that ANP32A deficiency reduced histone H3 acetylation, in accordance with changes in gene expression. Notably, significant histone H3 acetylation enrichment was associated with mRNA changes in lipid-related genes, including APOC1, PCSK9, P2RX1, and LPPR3. Indeed, over-expression of APOC1 partially compensated the proliferation-defect phenotype in ANP32A deficient AML cells while APOC1 knockdown alone mimicked the effect of ANP32A deficiency. Collectively, our data indicate that ANP32A is a novel regulator of histone H3 acetylation and promotes leukemogenesis.",
author = "Xuejing Yang and Bin Lu and Xueqin Sun and Cuijuan Han and Chunling Fu and Kailin Xu and Min Wang and Dengju Li and Zhichao Chen and Puneet Opal and Qiang Wen and Crispino, {John D.} and Wang, {Qian Fei} and Zan Huang",
year = "2018",
month = "7",
day = "1",
doi = "10.1038/s41375-018-0010-7",
language = "English (US)",
volume = "32",
pages = "1587--1597",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "7",

}

Yang, X, Lu, B, Sun, X, Han, C, Fu, C, Xu, K, Wang, M, Li, D, Chen, Z, Opal, P, Wen, Q, Crispino, JD, Wang, QF & Huang, Z 2018, 'ANP32A regulates histone H3 acetylation and promotes leukemogenesis', Leukemia, vol. 32, no. 7, pp. 1587-1597. https://doi.org/10.1038/s41375-018-0010-7

ANP32A regulates histone H3 acetylation and promotes leukemogenesis. / Yang, Xuejing; Lu, Bin; Sun, Xueqin; Han, Cuijuan; Fu, Chunling; Xu, Kailin; Wang, Min; Li, Dengju; Chen, Zhichao; Opal, Puneet; Wen, Qiang; Crispino, John D.; Wang, Qian Fei; Huang, Zan.

In: Leukemia, Vol. 32, No. 7, 01.07.2018, p. 1587-1597.

Research output: Contribution to journalArticle

TY - JOUR

T1 - ANP32A regulates histone H3 acetylation and promotes leukemogenesis

AU - Yang, Xuejing

AU - Lu, Bin

AU - Sun, Xueqin

AU - Han, Cuijuan

AU - Fu, Chunling

AU - Xu, Kailin

AU - Wang, Min

AU - Li, Dengju

AU - Chen, Zhichao

AU - Opal, Puneet

AU - Wen, Qiang

AU - Crispino, John D.

AU - Wang, Qian Fei

AU - Huang, Zan

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Deregulation of key regulators of histone modification is important in the initiation and progression of human leukemia. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) participates in histone acetylation and its role in acute myeloid leukemia remains unclear. Here we observed significant upregulation of ANP32A in primary AML cells, which was essential for AML cell proliferation, survival, and colony formation. Integrative analysis of the genome-wide histone H3 acetylation and gene expression demonstrated that ANP32A deficiency reduced histone H3 acetylation, in accordance with changes in gene expression. Notably, significant histone H3 acetylation enrichment was associated with mRNA changes in lipid-related genes, including APOC1, PCSK9, P2RX1, and LPPR3. Indeed, over-expression of APOC1 partially compensated the proliferation-defect phenotype in ANP32A deficient AML cells while APOC1 knockdown alone mimicked the effect of ANP32A deficiency. Collectively, our data indicate that ANP32A is a novel regulator of histone H3 acetylation and promotes leukemogenesis.

AB - Deregulation of key regulators of histone modification is important in the initiation and progression of human leukemia. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) participates in histone acetylation and its role in acute myeloid leukemia remains unclear. Here we observed significant upregulation of ANP32A in primary AML cells, which was essential for AML cell proliferation, survival, and colony formation. Integrative analysis of the genome-wide histone H3 acetylation and gene expression demonstrated that ANP32A deficiency reduced histone H3 acetylation, in accordance with changes in gene expression. Notably, significant histone H3 acetylation enrichment was associated with mRNA changes in lipid-related genes, including APOC1, PCSK9, P2RX1, and LPPR3. Indeed, over-expression of APOC1 partially compensated the proliferation-defect phenotype in ANP32A deficient AML cells while APOC1 knockdown alone mimicked the effect of ANP32A deficiency. Collectively, our data indicate that ANP32A is a novel regulator of histone H3 acetylation and promotes leukemogenesis.

UR - http://www.scopus.com/inward/record.url?scp=85042236808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042236808&partnerID=8YFLogxK

U2 - 10.1038/s41375-018-0010-7

DO - 10.1038/s41375-018-0010-7

M3 - Article

C2 - 29467488

AN - SCOPUS:85042236808

VL - 32

SP - 1587

EP - 1597

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 7

ER -

Yang X, Lu B, Sun X, Han C, Fu C, Xu K et al. ANP32A regulates histone H3 acetylation and promotes leukemogenesis. Leukemia. 2018 Jul 1;32(7):1587-1597. https://doi.org/10.1038/s41375-018-0010-7